These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2661281

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Effects of early introduction of intensive insulin therapy on the clinical course in non-obese NIDDM patients.
    Kayashima T, Yamaguchi K, Konno Y, Nanimatsu H, Aragaki S, Shichiri M.
    Diabetes Res Clin Pract; 1995 May; 28(2):119-25. PubMed ID: 7587919
    [Abstract] [Full Text] [Related]

  • 46. C-peptide in diabetes mellitus treated with insulin. A 3-year epidemiological study on the island of Falster, Denmark.
    Nielsen NV, Tronier B.
    Diabetes Res; 1986 Nov; 3(9):475-8. PubMed ID: 3549123
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Remission of insulin requirement in late secondary failure to oral hypoglycemic agents (IRD): results at 24 months and analysis of predictive factors.
    Grulet H, Gross A, Pasqual C, Durlach V, Leutenegger M.
    Diabetes Res Clin Pract; 1991 Sep; 13(3):189-98. PubMed ID: 1959482
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Factors associated with long-term oral hypoglycemic agent responsiveness in korean patients with type 2 diabetes mellitus.
    Kim BY, Jung CH, Mok JO, Kim CH.
    Diabetes Metab J; 2011 Jun; 35(3):282-9. PubMed ID: 21785749
    [Abstract] [Full Text] [Related]

  • 52. Evaluation of perception of insulin therapy among Chinese patients with type 2 diabetes mellitus.
    Chen CC, Chang MP, Hsieh MH, Huang CY, Liao LN, Li TC.
    Diabetes Metab; 2011 Nov; 37(5):389-94. PubMed ID: 21458350
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus.
    Erkens JA, Herings RM, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG.
    J Clin Epidemiol; 2002 Apr; 55(4):345-9. PubMed ID: 11927201
    [Abstract] [Full Text] [Related]

  • 60. Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database.
    Mazzi S, Ravasio R, Forlani G, Veronese G, Fabbri A, Marchesini G.
    Clinicoecon Outcomes Res; 2017 Apr; 9():711-720. PubMed ID: 29200880
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.